Serum Lipoprotein(a) Levels and Their Association with Atherosclerotic Cardiovascular Disease in Japan
Journal of Atherosclerosis and Thrombosis · 2025
DOI: 10.5551/jat.64953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Emi Fujii und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs Division, Novartis Pharma K.K. Hauptthemen laut MEDLINE: Lipoprotein(a), Atherosclerosis, Biomarkers, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Affairs Division, Novartis Pharma K.K.
- Department of Cardiovascular Medicine, Kitasato University School of Medicine.
- Department of Cardiology, Rinku General Medical Center.
Zitieren
APA
Fujii, E., Ako, J., Takahashi, Y., Toda, M., Iekushi, K., & Yamashita, S. (2025). Serum Lipoprotein(a) Levels and Their Association with Atherosclerotic Cardiovascular Disease in Japan. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64953
Vancouver
Fujii E, Ako J, Takahashi Y, Toda M, Iekushi K, Yamashita S. Serum Lipoprotein(a) Levels and Their Association with Atherosclerotic Cardiovascular Disease in Japan. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.64953
BibTeX
@article{Fujii2025,
author = {Fujii, Emi and Ako, Junya and Takahashi, Yuri and Toda, Mitsutoshi and Iekushi, Kazuma and Yamashita, Shizuya},
title = {Serum Lipoprotein(a) Levels and Their Association with Atherosclerotic Cardiovascular Disease in Japan},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2025},
doi = {10.5551/jat.64953}
}
EUVIMED